## Early Clinical Distinguishing Features of Lewy Body Dementia **Key Point:** Prominent visual hallucinations occurring early in the disease course, often with preserved insight (patient awareness that hallucinations are not real), are a hallmark feature that distinguishes LBD from Alzheimer's dementia. ### Characteristic Hallucinations in LBD - **Content:** Typically vivid, detailed, and recurrent (people, animals, children) - **Timing:** Often occur in evening or low-light conditions - **Insight:** Patients often retain awareness that hallucinations are not real - **Frequency:** Present in 50–80% of LBD patients ### Diagnostic Criteria Comparison | Feature | Lewy Body Dementia | Alzheimer's Dementia | |---|---|---| | **Early hallucinations** | Prominent (core feature) | Uncommon early | | **Initial memory loss** | Variable; may be subtle | Prominent, progressive | | **Parkinsonism** | Common (rigidity, bradykinesia) | Absent | | **REM sleep behavior disorder** | Frequent | Rare | | **Fluctuating cognition** | Marked day-to-day variation | Gradual, progressive | | **Sensitivity to antipsychotics** | Severe (neuroleptic sensitivity) | Moderate | **High-Yield:** The **DLB Consortium Criteria** list visual hallucinations as a core diagnostic feature. Two core features (parkinsonism, hallucinations, REM sleep behavior disorder, or cognitive fluctuation) are needed for probable LBD diagnosis. **Warning:** Antipsychotic medications can cause severe adverse reactions (neuroleptic malignant syndrome, worsening parkinsonism) in LBD patients — a critical clinical distinction from Alzheimer's management. **Clinical Pearl:** The presence of early visual hallucinations with preserved insight should immediately raise suspicion for LBD rather than Alzheimer's, prompting appropriate diagnostic workup and medication avoidance.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.